Recent Finacing
Recent Raise
Artcline develops ARTICE, an immune cell-based extracorporeal sepsis therapy using healthy donor immune cells to temporarily assume immune functions and reactivate patients' immunity; conducting a randomized ICU trial.
Focus Areas
Total Raised
Funding round
See the team members at Artcline.
